Although BMLs may be the result of trauma [ 35, 36] or malalignment [ 16], there is also evidence that they may be affected by systemic factors [ 37, 38].
Since the organ perfusion was proven to be affected by systemic hemodynamics, early goal-directed therapy (EGDT), which aims to correct circulatory failure [ 7], may prevent AKI.
However, plasma concentrations of some micronutrients may be affected by systemic inflammation, which may confound the low plasma concentrations, which indicate deficiency [ 32, 33].
These techniques may underestimate the response to systemic therapy, as the image incorporates tumour desmoplasia, which is prevalent in pancreatic tumour growth and is unlikely to be affected by systemic therapy.
It is of note that LPS administered at 12 weeks postinoculation with prion disease did not affect motor coordination, consistent with the idea that as pathology becomes more global, later in disease, the range of functions that may be affected by systemic inflammation becomes broader.
Subjects who had undergone previous lumbar surgery, who were affected by systemic diseases (e.g., inflammatory or infectious pathologies, cancer, etc)., spinal specific pathologies (e.g., spinal stenosis, inflammatory spinal diseases such as ankylosing spondylitis, discitis, and arachnoiditis), neuromuscular disorders, cognitive deficits, or who did not sign the informed consent were excluded.
Women who were affected by systemic, infectious, cardiac, and renal diseases and also systemic lupus erythematosus were excluded.
Women who are affected by systemic, infectious, cardiac, and renal diseases and systemic lupus erythematosus were excluded.
The relaxin concentration in serum is affected by systemic conditions such as pregnancy, heart failure, and cancer [ 3, 29, 30].
In patients, it is unknown whether luminal concentrations of lactate reflect mucosal values or whether they are affected by systemic lactate.
Studies in mice indicate that the number of circulating EPCs is affected by systemic exposure to angiogenic regulators such as VEGF and can decline in response to antiangiogenic therapy such as anti-VEGFR2 antibody therapy (Shaked et al, 2005).
